IDH1 and glioblastoma: The current predominant molecular phenotype classification of GBM is based on single amino acid missense mutations in isocitrate dehydrogenase1 (IDH1), which facilitates the classification of GBM into IDH1 wild‐type (IDH1WT) and IDH1 mutant‐type (IDH1Mut).